BRAIN HEART INFUSION (BHI) AGAR

Cat. no. L35 BHI Agar, 20x125mm Tube, 10ml Slant 20 or 100 tubes/box
Cat. no. W15 BHI Agar, 15x100mm Plate, 26ml 10 plates/bag
Cat. no. X10 BHI Agar, 50ml HardyFlask™, 12ml Slant 20 flasks/box
Cat. no. A20 BHI Agar with Blood, 15x100mm Plate, 18ml 10 plates/bag
Cat. no. W185 BHI Agar with Blood, 25x100mm Plate, 37ml 5 plates/bag
Cat. no. X13 BHI Agar with Blood, 50ml HardyFlask™, 12ml 20 flasks/box
Cat. no. L31 BHI Agar with Blood, 20x125mm Tube, 10ml Slant 20 or 100 tubes/box
Cat. no. X12 BHI Agar with Blood and Gentamicin, 50ml HardyFlask™,
12ml
20 flasks/box
Cat. no. W65 BHI Agar with Blood, Chloramphenicol and Gentamicin,
15x100mm Plate, 26ml
10 plates/bag
Cat. no. X14 BHI Agar with Blood, Chloramphenicol and Gentamicin,
50ml HardyFlask™, 12ml
20 flasks/box
Cat. no. L33 BHI Agar with Chloramphenicol and Cycloheximide,
20x125mm Tube, 10ml
20 or 100 tubes/box
Cat. no. X11 BHI Agar with Chloramphenicol and Cycloheximide
50ml HardyFlask™, 12ml
20 flasks/box
Cat. no. W186 BHI Agar with Chloramphenicol and Gentamicin, 25x100mm
Plate, 37ml
5 plates/bag
Cat. no. K07 BHI with Agar and Fildes, 16x100mm Tube, 6ml Deep 20 or 100 tubes/box

INTENDED USE

Hardy Diagnostics Brain Heart Infusion (BHI) Agar is a general purpose nutrient medium recommended for the cultivation and isolation of a variety of microorganisms, including bacteria, yeasts, and molds. Media enriched with Fildes is useful for cultivating capsular strains of Haemophilus influenzae. The addition of defibrinated sheep blood and antimicrobics produces a selective medium used for the isolation of pathogenic fungi from specimens heavily contaminated with bacteria and saprophytic fungi.(2)

SUMMARY

Rosenow, by adding brain tissue to dextrose broth, discovered a medium useful in the cultivation of streptococci.(8) Formula modifications were made by various researchers who found the medium effective in the recovery of dental pathogens.(4,5,8) The medium was further modified by the addition of agar and a variety of supplements and enrichments which further enhanced the recovery of microorganisms.

The brain heart infusion, peptone and dextrose components of the medium provide the nutrients to BHI Agar. Organic nitrogen, carbon, sulfur, vitamins and trace substances are provided by the peptones and infusion. Dextrose provides the carbohydrate source for fermentative microorganisms. Disodium phosphate is added to the medium in order to maintain an optimal pH. Additionally, a variety of supplements has been added to further enhance the recovery of fastidious microorganisms.

BHI with Agar and Fildes is a semi-solid medium used for organisms requiring blood derivatives, especially Haemophilus spp. Fildes is a peptic digest of sheep blood which is rich in X- and V-factors.(11,12)

BHI Agar with Blood is used for the recovery of fungal species.(13) Blood provides essential growth factors for the more fastidious fungal organisms.

BHI Agar with Blood, Gentamicin and Chloramphenicol is used for the selective isolation of fungi from specimens heavily contaminated with bacteria.(2) Gentamicin inhibits the growth of gram-negative and some gram-positive bacteria. A wide range of gram-positive and gram-negative bacteria are inhibited by chloramphenicol, a broad-spectrum antimicrobic.

BHI Agar with Chloramphenicol and Cycloheximide is used for the selective isolation of pathogenic fungi. Cycloheximide inhibits saprophytic fungi while Chloramphenicol acts as an antibacterial agent. The incorporation of both antimicrobics achieves more complete selectivity against growth of saprophytic fungi and bacteria.(2)

FORMULA

Ingredients per liter of deionized water:*

BHI Agar:
Pancreatic Digest of Casein 16.0gm
Brain Heart Infusion from Solids 10.0gm
Peptic Digest of Animal Tissue 5.0gm
Sodium Chloride 3.0gm
Disodium Phosphate 2.5gm
Dextrose 2.0gm
Agar 13.5gm
BHI Agar with Blood:
In addition to the above formulation, contains:
Sheep Blood 50.0ml
BHI Agar with Blood and Gentamicin:
In addition to the above formulation, contains:
Gentamicin 5.0mg
Sheep Blood 50.0ml
BHI Agar with Chloramphenicol and Gentamicin**:
In addition to the above formulation, contains:
Chloramphenicol 50.0mg
Gentamicin 5.0mg
BHI Agar with Blood, Chloramphenicol and Gentamicin**:
In addition to the above formulation, contains:
Chloramphenicol 50.0mg
Gentamicin 5.0mg
Sheep Blood 50.0ml
BHI Agar with Chloramphenicol and Cycloheximide**:
Pancreatic Digest of Casein 16.0gm
Brain Heart Infusion 8.0gm
Peptic Digest of Animal Tissue 5.0gm
Sodium Chloride 5.0gm
Disodium Phosphate 2.5gm
Dextrose 2.0gm
Cycloheximide 0.5gm
Chloramphenicol 0.05gm
Agar 13.5gm
BHI with Agar and Fildes:
Pancreatic Digest of Casein 14.5gm
Brain Heart Infusion from Solids 10.0gm
Peptic Digest of Animal Tissue 5.0gm
Sodium Chloride 3.0gm
Disodium Phosphate 2.5gm
Dextrose 2.0gm
Fildes Supplement 20.0ml
Agar 2.5gm

Final pH 7.4 +/- 0.3 at 25 degrees C.

* Adjusted and/or supplemented as required to meet performance criteria.

** This media contains chloramphenicol and/or cycloheximide which are ingredients considered potentially hazardous.

Refer to the keyword "MSDS Introduction", in the Hardy Diagnostics software program HUGO™, for more information on handling potentially hazardous material.

STORAGE AND SHELF LIFE

Storage: Upon receipt store all BHI Agar products* at 2-8 degrees C. (*except Cat. no. L33, L35, X10 and X11). Products L33, L35, X10 and X11 may be stored at 2-30 degrees C. Products should not be used if there are any signs of contamination, deterioration (shrinking, cracking, or discoloration), hemolysis, contamination, or if the expiration date has passed. Product is light and temperature sensitive; protect from light, excessive heat and freezing.

The expiration date applies to the product in its intact packaging when stored as directed.

This product, depending on its formulation, has the following shelf life from the date of manufacture:

90 Days: A20 BHI Agar with Blood
W15 BHI Agar
W65 BHI Agar with Blood, Chloramphenicol, and Gentamicin
W185 BHI Agar with Blood
W186 BHI Agar with Chloramphenicol, and Gentamicin
120 Days: L31 BHI Agar with Blood
X10 BHI Agar
X11 BHI Agar with Chloramphenicol and Cycloheximide
X12 BHI Agar with Blood and Gentamicin
X13 BHI Agar with Blood
X14 BHI Agar with Blood, Chloramphenicol and Gentamicin
180 Days: K07 BHI with Agar and Fildes
365 Days: L33 BHI Agar with Chloramphenicol and Cycloheximide
L35 BHI Agar

Refer to the keyword "Storage", in the Hardy Diagnostics software program HUGO™, for more information on storing culture media.

PRECAUTIONS

This product is for in vitro diagnostic use only and is to be used only by adequately trained and qualified laboratory personnel. Observe approved biohazard precautions and aseptic techniques. All laboratory specimens should be considered infectious and handled according to "standard precautions". The "Guideline for Isolation Precautions" is available from the Centers of Disease Control and Prevention at www.cdc.gov/ncidod/dhqp/gl_isolation.html.

For additional information regarding specific precautions for the prevention of the transmission of all infectious agents from laboratory instruments and materials, and for recommendations for the management of exposure to infectious disease, refer to CLSI document M29.

Sterilize all biohazard waste before disposal.

Refer to the keyword "Precautions", in the Hardy Diagnostics software program HUGO™, for more information regarding general precautions when using culture media.

Refer to the keyword "MSDS", in the Hardy Diagnostics software program HUGO™, for more information on handling potentially hazardous material.

PROCEDURE

Specimen Collection: Consult listed references for information on specimen collection.(1-3,6) Infectious material should be submitted directly to the laboratory without delay and protected from excessive heat and cold. If there is to be a delay in processing, the specimen should be inoculated onto an appropriate transport medium and refrigerated until inoculation.

Method of Use for Cultivation and Isolation of Bacteria: Consult listed references for the appropriate cultivation techniques using this medium.(1-3,6) Medium should be brought to room temperature and agar surface should be dry prior to inoculation. If the specimen to be cultured is on a swab, roll the swab over a small area of the agar surface. Streak for isolation with a sterile loop. Incubate plates aerobically at 35 +/- 2.0 degrees C. for 24 to 48 hours. Protect from light. Examine plates for colonial morphology.

Method of Use for Cultivation and Isolation of Fungi: A selective and non-selective medium should be inoculated for isolation of fungi from potentially contaminated specimens. Media should be incubated at room temperature (15-30 degrees C.) with increased humidity. Two sets of media should be inoculated for isolation of fungi causing systemic mycoses; one set incubated at 15-30 degrees C. and one set at 35 +/- 2.0 degrees C. Cultures should be examined weekly for fungal growth. Media should be held for four to six weeks before being reported as negative.

BHI Agar slants (without supplements or antimicrobics) are used primarily for the cultivation and maintenance of pure cultures of microorganisms.

INTERPRETATION OF RESULTS

Media should be examined for typical bacterial and fungal colonial morphology. Consult listed references for the interpretation of growth and other identification tests to identify growth of organism(s) on this media.(1-3,6)

LIMITATIONS

It is recommended that biochemical and/or serological tests be performed on colonies from pure culture for complete identification.(1-3,6)

Refer to the keyword "Limitations", in the Hardy Diagnostics software program HUGO™, for more information regarding general limitations on culture media.

MATERIALS REQUIRED BUT NOT PROVIDED

Standard microbiological supplies and equipment such as loops, other culture media, swabs, applicator sticks, incinerators, and incubators, etc., as well as serological and biochemical reagents, are not provided.

QUALITY CONTROL

The following organisms are routinely used for testing at Hardy Diagnostics:

Test Organisms Inoculation Method* Incubation Results
Time Temperature Atmosphere
BHI Agar:
Escherichia coli
ATCC® 25922
A 24-48hr 35°C Aerobic Growth
Staphylococcus aureus
ATCC® 25923
A 24-48hr 35°C Aerobic Growth
Staphylococcus epidermidis
ATCC® 12228
A 24-48hr 35°C Aerobic Growth
BHI Agar with Blood:
Streptococcus pyogenes
ATCC® 19615
A 18-24hr 35°C Aerobic Growth; beta-hemolysis
Streptococcus pneumoniae
ATCC® 6305
A 18-24hr 35°C Aerobic Growth; alpha-hemolysis
Aspergillus brasiliensis
formerly A. niger
ATCC® 16404
G 5-7 days 30°C Aerobic Growth
Staphylococcus aureus
ATCC® 25923
A 18-24hr 35°C Aerobic Growth
Escherichia coli
ATCC® 25922
A 18-24hr 35°C Aerobic Growth
BHI Agar with Blood and Gentamicin / BHI Agar with Chloramphenicol, and Gentamicin / BHI Agar with Blood, Chloramphenicol, and Gentamicin:
Candida albicans
ATCC® 10231
A 18-24hr 35°C Aerobic Growth
Trichophyton mentagrophytes
ATCC® 9533
G 7 days 15-30°C Aerobic Growth
Escherichia coli
ATCC® 25922
B 18-24hr 35°C Aerobic Partial to complete inhibition
Pseudomonas aeruginosa
ATCC® 27853
B 24hr 35°C Aerobic Partial to complete inhibition
BHI Agar with Chloramphenicol and Cycloheximide:
Candida albicans
ATCC® 10231
A 18-24hr 35°C Aerobic Growth
Trichophyton mentagrophytes
ATCC® 9533
G 7 days 15-30°C Aerobic Growth
Escherichia coli
ATCC® 25922
B 18-24hr 35°C Aerobic Partial to complete inhibition
Aspergillus brasiliensis
formerly A. niger
ATCC® 16404
G 7 days 15-30°C Aerobic Partial to complete inhibition
BHI with Agar and Fildes:
Haemophilus influenzae
ATCC® 10211
D 24hr 35°C Aerobic Growth

User Quality Control

Check for signs of contamination and deterioration. Users of commercially prepared media may be required to perform quality control testing with at least one known organism to demonstrate growth or a positive reaction; and at least one organism to demonstrate inhibition or a negative reaction (where applicable). Refer to the following keywords, in the Hardy Diagnostics software program HUGO™, for more information on QC: "Introduction to QC", "QC of Finished Product", and "The CLSI (NCCLS) Standard and Recommendations for User QC of Media". Also see listed references for more information.(1-3,6,10)

* Refer to the keyword "Inoculation Procedures", in the Hardy Diagnostics software program HUGO™, for a description of inoculation procedures.

PHYSICAL APPEARANCE

BHI Agar

Sterile plate of BHI Agar (Cat. no. W15).

E. coli growing on BHI Agar

Escherichia coli (ATCC® 25922) colonies growing on BHI Agar (Cat. no. W15). Incubated aerobically for 24 hours at 35 deg. C.

BHI Agar with Blood

Uninoculated plate of BHI Agar with Blood (Cat. no. A20).

C. albicans growing on BHI Agar with Blood, Chloramphenicol and Gentamicin

Candida albicans (ATCC® 10231) colonies growing on BHI Agar with Blood, Chloramphenicol and Gentamicin (Cat. no. W65). Incubated aerobically for 24 hours at 35 deg. C.

P. pneumoniae growing on BHI Agar with Blood

Streptococcus pneumoniae (ATCC® 6305) colonies growing on BHI Agar with Blood (Cat. no. A20). Incubated aerobically for 24 hours at 35 deg. C.

E. coli inhibited on BHI Agar with Blood, Chloramphenicol and Gentamicin

Escherichia coli (ATCC® 25922) growth inhibited on BHI Agar with Blood, Chloramphenicol and Gentamicin (Cat. no. W65). Incubated aerobically for 24 hours at 35 deg. C.

T. mentagrophytes growing on BHI Agar with Blood, Chloramphenicol and Gentamicin

Trichophyton mentagrophytes (ATCC® 9533) colonies growing on BHI Agar with Blood, Chloramphenicol and Gentamicin (Cat. no. W65). Incubated aerobically for 96 hours at 30 deg. C.

C. albicans growing on a BHI Slant with Chloramphenicol and Cycloheximide

Candida albicans (ATCC® 10231) colonies growing on BHI Agar with Chloramphenicol and Cycloheximide (Cat. no. L33). Incubated aerobically for 24 hours at 35 deg. C.

E. coli inhibited on BHI Agar with Chloramphenicol and Cycloheximide

Escherichia coli (ATCC® 25922) growth inhibited on BHI Agar with Chloramphenicol and Cycloheximide (Cat. no. L33). Incubated aerobically for 24 hours at 35 deg. C.

REFERENCES

1. August, M.J., et al. 1990. Cumitech 3A; Quality Control and Quality Assurance Practices in Clinical Microbiology, Coordinating ed., A.S. Weissfeld. American Society for Microbiology, Washington, D.C.

2. Murray, P.R., et al. 1995. Manual of Clinical Microbiology, 6th ed. American Society for Microbiology, Washington, D.C.

3. Forbes, B.A., et al. 1998. Bailey and Scott's Diagnostic Microbiology, 10th ed. C.V. Mosby Company, St. Louis, MO.

4. Falk, C.R., et al. 1939. J. Bacteriol.; 37:121.

5. Haden, R.L. 1932. Arch. Internal Med.; 32:828.

6. Isenberg, H.D. Clinical Microbiology Procedures Handbook, Vol. I & II. American Society for Microbiology, Washington, D.C.

7. MacFaddin, J.F. 1985. Media for Isolation, Cultivation, Identification, Maintenance of Bacteria, Vol. I. Williams & Wilkins, Baltimore, MD.

8. Hitchens, A.P. 1921. J. Infect. Disease; 29:390.

9. Rosenow, E.C. 1919. J. Dental Research; 1:205.

10. Quality Assurance for Commercially Prepared Microbiological Culture Media. 1996. M22-A2, Vol. 16, No. 16. Clinical Laboratory Standards Institute (CLSI - formerly NCCLS), Villanova, PA.

11. Fildes, P. 1920. Br. J. Exp. Pathol.; 1:129.

12. Fildes, P. 1921. Br. J. Exp. Pathol.; 2:16.

13. Creitz and Puckett. 1954. J. Clin. Pathol.; 24:1318.

14. J. Chron. Dis.; 5:545, 1957.

15. J. Lab and Clin. Med.; 55:116, 1960.


ATCC is a registered trademark of the American Type Culture Collection.

102208mg